Perfil de presión uretral / Urethral pressure profile

The "urethral pressure profile" is a graph indicating the intraluminal pressure along the length of the urethra and the "urethral closure pressure profile" is given by the substraction of intravesical pressure (pves) from urethral pressure (pura). Both aim to represent the ability of the urethra to prevent involuntary leakage of urine on efforts or exertion. The continuous measurement of pves also allows the detection of detrusor contractions. In this article we will refer to its terminology, the necessary equipment to carry it out, the examination technique, its morphology in women and men, and the stress urethral pressure profile in women. The most important parameter is the "maximum urethral closure pressure", which is the maximum difference between pura and pves; a value ≤ 20 cm H2O participates in the urodynamic definition of intrinsic sphincter deficiency (together with an abdominal leak point pressure ≤ 60 cm H2O). However, it must be taken into account that the different techniques used for its measurement has led to inconsistent results, which makes their acceptance in clinical practice difficult. (AU)

Effect of S-methyl-l-thiocitrulline dihydrochloride on rat micturition reflex

ABSTRACT Objective: To evaluate the effect of neuronal nitric oxide synthase on the striated urethral sphincter and the urinary bladder. Materials and Methods: A coaxial catheter was implanted in the proximal urethra and another one in the bladder of female rats, which were anesthetized with subcutaneous injection of urethane. The urethral pressure with saline continuous infusion and bladder isovolumetric pressure were simultaneously recorded. Two groups of rats were formed. In group I, an intrathecal catheter was implanted on the day of the experiment at the L6-S1 level of the spinal cord; in group II, an intracerebroventricular cannula was placed 5-6 days before the experiment. Results: It was verified that the group treated with S-methyl-L-thio-citrulline, via intrathecal pathway, showed complete or partial inhibition of the urethral sphincter relaxation and total inhibition of the micturition reflexes. The urethral sphincter and the detrusor functions were recovered after L-Arginine administration. When S-methyl-L-thio-citrulline was administered via intracerebroventricular injection, there was a significant increase of urethral sphincter tonus while preserving the sphincter relaxation and the detrusor contractions, at similar levels as before the use of the drugs. Nevertheless there was normalization of the urethral tonus when L-Arginine was applied. Conclusions: The results indicate that, in female rats anaesthetized with urethane, the nNOS inhibitor administrated through the intrathecal route inhibits urethral sphincter relaxation, while intracerebroventricular injection increases the sphincter tonus, without changing bladder function. These changes were reverted by L-Arginine administration. These findings suggest that the urethral sphincter and detrusor muscle function is modulated by nitric oxide.

Can intraurethral stimulation inhibit micturition reflex in normal female rats?

ABSTRACT Objective The study was designed to determine the effect of low frequency (2.5Hz) intraurethral electrical stimulation on bladder capacity and maximum voiding pressures. Materials and Methods The experiments were conducted in 15 virgin female Sprague-Dawley rats (220–250g). The animals were anesthetized by intraperitoneal injection of urethane (1.5g/kg). Animal care and experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee of Antwerp University (code: 2013-50). Unipolar square pulses of 0.06mA were used to stimulate urethra at frequency of 2.5Hz (0.2ms pulse width) in order to evaluate the ability of intraurethral stimulation to inhibit bladder contractions. Continuous stimulation and intermittent stimulation with 5sec ‘‘on’’ and 5sec ‘‘off’’ duty cycle were applied during repeated saline cystometrograms (CMGs). Maximum voiding pressures (MVP) and bladder capacity were investigated to determine the inhibitory effect on bladder contraction induced by intraurethral stimulation. Results The continuous stimulation and intermittent stimulation significantly (p<0.05) decreased MVP and increased bladder capacity. There was no significant difference in MVP and bladder capacity between continuous and intermittent stimulation group. Conclusions The present results suggest that 2.5Hz continuous and intermittent intraurethral stimulation can inhibit micturition reflex, decrease MVP and increase bladder capacity. There was no significant difference in MVP and bladder capacity between continuous and intermittent stimulation group.

Human Amniotic Fluid Stem Cell-derived Muscle Progenitor Cell Therapy for Stress Urinary Incontinence

The most promising treatment for stress urinary incontinence can be a cell therapy. We suggest human amniotic fluid stem cells (hAFSCs) as an alternative cell source. We established the optimum in vitro protocol for the differentiation from hAFSCs into muscle progenitors. These progenitors were transplanted into the injured urethral sphincter and their therapeutic effect was analyzed. For the development of an efficient differentiation system in vitro, we examined a commercial medium, co-culture and conditioned medium (CM) systems. After being treated with CM, hAFSCs were effectively developed into a muscle lineage. The progenitors were integrated into the host urethral sphincter and the host cell differentiation was stimulated in vivo. Urodynamic analysis showed significant increase of leak point pressure and closing pressure. Immunohistochemistry revealed the regeneration of circular muscle mass with normal appearance. Molecular analysis observed the expression of a larger number of target markers. In the immunogenicity analysis, the progenitor group had a scant CD8 lymphocyte. In tumorigenicity, the progenitors showed no teratoma formation. These results suggest that hAFSCs can effectively be differentiated into muscle progenitors in CM and that the hAFSC-derived muscle progenitors are an accessible cell source for the regeneration of injured urethral sphincter.

Intraoperative maximal urethral closing pressure measurement: a new technique of tape tension adjustment in transobturator sling surgery?

PURPOSE: Tape tension adjustment is an essential procedure in mid-urethral sling surgery. The goal of this study was to determine if intraoperative maximal urethral closing pressure (MUCP) elevation could be used as a reference value for adequate tape tension adjustment and predict transobturator (TOT) sling surgery outcome. MATERIALS AND METHODS: A prospective study was performed using MUCP measurements just before tape insertion and just after tension adjustment during surgery. Clinical data including preoperative urodynamic results were collected. The cure rate was determined by questionnaire. Patients were divided into two groups. The MUCP elevation group included patients with a MUCP elevation of more than 10 cmH2O before tape insertion; the others were regarded as the non-elevation group. The cure rate and pre- and postoperative clinical variables were compared between the two groups. RESULTS: A total of 48 patients had TOT surgery. The MUCP elevation group (n=19) and the non-elevation group (n=29) were similar with regard to patient characteristics and the preoperative parameters including age, mixed incontinence prevalence, Q-tip angle, peak flow rate, MUCP and the valsalva leak point pressure (VLPP). The mean follow-up period was nine months. The cure rate was significantly higher in the group with MUCP elevation than in the non-elevation group (84 percent vs. 52 percent, p=0.02). There was no significant difference in the mean postoperative peak flow rate between the two groups and there was no retention episode. CONCLUSIONS: MUCP elevation of more than 10 cmH2O just after tape insertion was a prognostic factor.

Efeitos das isoflavonas sobre o assoalho pélvico e a vascularização peri-uretral de mulheres na pós-menopausa / Effects of isoflavones on the pelvic floor and the periurethral vascularization of postmenopausal women

OBJETIVO: avaliar a força muscular do assoalho pélvico e os vasos periuretrais de mulheres na pós-menopausa, antes e após seis meses de uso contínuo de extrato de soja. MÉTODOS: estudo prospectivo com 30 mulheres na pós-menopausa antes e após o uso de extrato de soja (100 mg/dia) durante seis meses consecutivos. Foram investigadas a perda urinária e a força muscular do assoalho pélvico por perineômetro digital e avaliação funcional. Avaliou-se ainda o número de vasos da região peri-uretral pela dopplervelocimetria. Para comparar os resultados antes e após tratamento, utilizou-se o teste pareado t de Student. RESULTADOS: das 30 mulheres analisadas, 20 referiram alguma forma de perda urinária no inicio do experimento. A melhora deste sintoma ocorreu em 15 (75 por cento) mulheres após o tratamento. A medida da pressão vaginal (força muscular do assoalho pélvico) foi 12,9±1,7 e 15,8±1,8 Sauers, respectivamente, antes e após o tratamento (p<0,001). Observou-se aumento da pressão em 22 (73,3 por cento) mulheres no final do estudo. Na avaliação funcional, verificou-se que 12 mulheres não sofreram alteração da função muscular do assoalho pélvico, ou seja, 18 (60 por cento) tiveram aumento da força muscular. Pelo exame ultra-sonográfico (Doppler) obtivemos no início do experimento 2,20±0,15 vasos sanguíneos/campo, passando para 3,4±0,2 vasos sanguíneos/campo ao final do experimento (p<0,001). Em 21 mulheres (70 por cento) registrou-se aumento do número dos vasos peri-uretrais após os seis meses de tratamento. CONCLUSÃO: ressalta-se que são resultados preliminares, havendo necessidade de outras investigações com número maior de participantes em estudo duplo-cego, randomizado e controlado por placebo. Contudo, o tratamento com extrato de soja, por seis meses consecutivos, determinaria aumento da força muscular do assoalho pélvico e do número de vasos peri-uretrais em mulheres na pós-menopausa.

PURPOSE: to evaluate muscular strength of the pelvic floor and the periurethral vessels of postmenopausal women before and after six months of soybean extract treatment. METHODS: the study was conducted on 30 postmenopausal women before and after six consecutive months of soyabean extract (100 mg/day) administration. Urinary loss and muscular strength of the pelvic floor were investigated through digital perineometer and functional evaluation. Digital color Doppler in the periurethral region was used to count the number of vessels. For statistical analysis, the paired Student t test was applied to compare the results before and after the treatment. RESULTS: twenty women reported urinary incontinence before the treatment period. The amelioration of this symptom was observed in 15 (75 percent) women after the treatment. Vaginal pressure (muscular strength of the pelvic floor) was 12.95±1.73 and 15.86±1.86 Sauers, before and after the treatment, respectively (p<0.001). Twenty-two women (73.3 percent) presented an increase in the pressure at the end of this study. In relation to the function evaluation, 18 (60 percent) had improvement in muscular strength and 12 women did not present any change. On ultrasonography (Doppler), the number of vessels was 2.20±0.15 blood vessels/field in the beginning of this study and 3.46±0.25 blood vessels/field at the end of the treatment (p<0.001). An increase in the number of periurethral vessels was detected in 21 women (70 percent). CONCLUSION: it is important to emphasize that these are preliminary results. A double blind randomized and placebo-controlled clinical trial with a high number of participants is necessary. However, the treatment with concentrated soybean extract (100 mg per day) for six consecutive months may determine an improvement in pelvic floor muscular strength and an increase in the number of periurethral vessels in postmenopausal women.

Relationship between Urinary Endogenous Steroid Metabolites and Lower Urinary Tract Function in Postmenopausal Women

To investigate the relationship between the endogenous steroid hormones and the lower urinary tract function in postmenopausal women. Thirty postmeopausal volunteer women who did not have lower urinary tract symptoms or hormone replacement therapy were enrolled in this study. Urodynamic studies included uroflowmetry, multi-channel cystometry, and urethral pressure profilometry were conducted. Gas Chromatography- Mass Spectroscopy (GC-MS) was used to measure the urinary endogenous steroid hormone metabolites. The relationship between the urinary profile of the endogenous steroids and the urodynamic parameters of these patients were investigated. The mean ages of the patients were 60.6 +/- 5.5 years, and the Body Mass Index (BMI) averaged 24.56 +/- 2.23 (kg/m2). Of the progesterone metabolites, pregnandiol was significantly related to the residual volume in the uroflowmetry and the functional urethral length parameters (R=0.98, p=0.000; R= -0.65, p=0.04). Pregnantriol was significantly related to the maximum flow rate, the residual volume in uroflowmetry, the maximum urethral closure pressure and the functional urethral length (R=-0.64, p=0.04; R=0.82, p=0.01; R=0.04, p=0.04; R=- 0.79, p=0.01). In the androgen metabolites, androstenedione, 5-AT, 11- keto Et, 11-betahydroxy Et, THS, and THE were significantly related to the residual volume in uroflowmetry (R=0.92, p=0.001; R=0.84, p=0.008; R=0.99, p=0.000; R=0.72, p=0.03; R=0.97, p=0.000; R=0.85, p=0.00). beta-THF/alpha-THF was significantly related to the maximum flow rate, the residual volume in uroflowmetry, the maximum urethral closure pressure and the functional urethral length (R=-0.76, p=0.02; R=0.67, p=0.04; R=0.74, p=0.02; R=-0.92, p=0.000). alpha-cortol was significantly related to the residual volume in uroflowmetry, the maximum urethral closure pressure and the functional urethral length (R=0.81, p=0.01; R=0.71, p=0.03; R=-0.87, p=0.000). Of the estrogen metabolites, estrone (E1) was significantly related to the normal desire to void (R=0.68, p=0.04) and 17 beta-estradiol/estrone was also significantly related to the normal and strong desire to void (R=-0.70, p=0.03 and R=-0.74, p=0.02, respectively). The urinary progesterone and androgen metabolite concentrations were positively related to the residual volume in uroflowmetry and positively or negatively related to MUCP and FUL. However, the urinary estrone concentration was positively related to the normal desire to void and 17 beta-estradiol/estrone was significantly related to the normal and strong desire to void.

Aplicación de estrógenos y acciones de enfermería en pacientes post-menopáusicas con incontinencia urinaria de esfuerzo / Estrogens vaginal administration and nursing care in post-menopausic patients with urinary incontinence

Se realizó un estudio prospectivo longitudinal abierto donde se estudiaron 29 pacientes con incontinencia urinaria de esfuerzo (IUE) demostrada clínica y urodinámicamente, las cuales fueron divididas en dos grupos, el primer grupo de 14 paciente recibió tratamiento con estrógenos (Premarin V 0.625 mg) en crema vaginal 2 g 2 veces al día durante 6 semanas; al segundo grupo de 15 pacientes se les enseñó un programa de ejercicios perineales (Kegel) 6 veces al día con una serie de 15 ejercicios durante 6 semanas. A los dos grupos se les determinó estradiol E2 en sangre al inicio del tratamiento y después del tratamiento sólo se les midió el nivel de estrógenos a las pacientes que recibieron tratamiento con los mismos, a ambos grupos se les realizó un perfil de presión uretral antes y después del tratamiento, tomando en cuenta la longitud funcional y la máxima presión de cierre en un perfil estático y dinámico. En los resultados obtenidos en el perfil de presión uretral al observar por separado los dos grupos, se encontró un incremento significativo en la máxima presión de cierre en el perfil estático en el grupo con ejercicios en relación con el de estrógenos (p=0.03) y al compararlos se vio un aumento significativo en la máxima presión de cierre en el perfil estático en el grupo con ejercicios en relación con el de estrógenos (p=0.03) y al compararlos se vio un aumento significativo en la longitud funcional dinámica del grupo con ejercicios en relación al de estrógenos (p=0.02). El resto de los valores tomados en cuenta en el perfil de presión uretral tuvieron un aumento pero éstos no fueron significativos. Los resultados obtenidos en relación a la sintomatología que presentaron las pacientes se observó una disminución en ambos grupos aunque esta mejoría fue mayor en el grupo con ejercicios

Incontinência urinária na mulher. Enfase ao tratamento farmacológico / Female urinary incontinence: pharmacological treatment approach

A incontinência urinária feminina é uma entidade muito freqüente na prática urológica e ginecológica, tendendo a se acentuar no periódo pós-menopausa. Muitas pacientes apresentam graus leve e moderado de perda urinária involuntária e näo procuram cuidados médicos. Este trabalho tem a finalidade de chamar a atençäo do clínico para esta patologia, bem como de fazer uma revisäo atual e objetiva sobre as principais alternativas medicamentosas para o tratamento clínico (näo invasivo) da incontinência urinária na mulher.